Results 151 to 157 of about 2,004 (157)
Some of the next articles are maybe not open access.

Summary of opinion: Ultomiris,ravulizumab

Case Medical Research, 2019
openaire   +2 more sources

Long‐Term Efficacy and Safety of Ravulizumab in Adults With Anti‐Acetylcholine Receptor Antibody‐Positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open‐Label Extension

European Journal of Neurology
Andreas Meisel   +2 more
exaly  

Ravulizumab and other complement inhibitors for the treatment of autoimmune disorders

Multiple Sclerosis and Related Disorders
Tania Kümpfel   +2 more
exaly  

Meningococcal vaccines/Ravulizumab

Reactions Weekly
openaire   +1 more source

Hocheffektive Schubprophylaxe mit Ravulizumab

InFo Neurologie + Psychiatrie
openaire   +1 more source

An evaluation of ravulizumab for the treatment of neuromyelitis optica spectrum disorder

Expert Opinion on Biological Therapy
Denis Balaban   +2 more
exaly  

Post marketing real-world experience of ravulizumab in NMOSD

Multiple Sclerosis and Related Disorders
Luai Eldweik   +2 more
exaly  
eculizumab
atypical hemolytic uremic syndrome
antibodies, monoclonal, humanized
humans
paroxysmal nocturnal hemoglobinuria
3. good health
myasthenia gravis
adult
thrombotic microangiopathy
previous   14  15  16  

Home - About - Disclaimer - Privacy